We found that ZNF367 was overexpressed in a variety of endocrine cancers (adrenocortical carcinoma, papillary thyroid cancer, malignant pheochromocytoma/paraganglioma) compared to benign and or normal tissue samples. Here, ZNF367 is linked to malignant endocrine neoplasm.